President & Immunovant CEO
Tue, Mar 17, 2026
Mar 17
200,000 shares @ $28.24
Decreased holdings by -10.80%
12th largest trade (out of 285)
Large Trade
Trade made by an officer
10b5-1 scheduled trade
33% win rate · -5.8% median edge vs SPY (82 trades, 90-day)
Price 58% above 200-day moving average